NYSE:PFE - Pfizer News Headlines

Sign in or create an account to add this stock to your watchlist.
$43.51 +0.30 (+0.69 %)
(As of 11/16/2018 04:00 PM ET)
Previous Close$43.21
Today's Range$42.9136 - $43.78
52-Week Range$33.20 - $45.81
Volume23.28 million shs
Average Volume22.20 million shs
Market Capitalization$259.07 billion
P/E Ratio16.42
Dividend Yield3.17%
Beta0.88

Headlines

Pfizer (NYSE PFE) News Headlines

Source:
DateHeadline
WSJ: Pfizer to reverse course, raise prices on 41 drugsWSJ: Pfizer to reverse course, raise prices on 41 drugs
seekingalpha.com - November 16 at 3:40 PM
Pfizer plans to increase U.S. drug prices in JanuaryPfizer plans to increase U.S. drug prices in January
finance.yahoo.com - November 16 at 3:40 PM
[$$] Pfizer to Raise Prices on 41 Drugs[$$] Pfizer to Raise Prices on 41 Drugs
finance.yahoo.com - November 16 at 3:40 PM
Final Trades: Virtu, JPMorgan & PfizerFinal Trades: Virtu, JPMorgan & Pfizer
finance.yahoo.com - November 16 at 3:40 PM
Pfizer to raise prices on 41 prescription drugs next year despite pressure from TrumpPfizer to raise prices on 41 prescription drugs next year despite pressure from Trump
finance.yahoo.com - November 16 at 3:40 PM
Top Research Reports for Pfizer, Cisco & Southern CompanyTop Research Reports for Pfizer, Cisco & Southern Company
www.zacks.com - November 16 at 10:06 AM
AstraZeneca Shows It Can Still Take Some KnocksAstraZeneca Shows It Can Still Take Some Knocks
finance.yahoo.com - November 16 at 10:06 AM
Global Hyperlipidemia Drugs Market Analysis (2016-2022): AstraZeneca, Merck, Pfizer, Daiichi Sankyo, Amgen and Sanofi are ProfiledGlobal Hyperlipidemia Drugs Market Analysis (2016-2022): AstraZeneca, Merck, Pfizer, Daiichi Sankyo, Amgen and Sanofi are Profiled
www.prnewswire.com - November 15 at 7:31 PM
Sangamo's Shares Drop on Rating Downgrade, Pipeline WoesSangamo's Shares Drop on Rating Downgrade, Pipeline Woes
finance.yahoo.com - November 15 at 3:37 PM
Why Pfizer Is Up 19% in 2018 So FarWhy Pfizer Is Up 19% in 2018 So Far
www.fool.com - November 15 at 8:54 AM
Pfizer (PFE) Earns Daily Media Impact Rating of 0.83Pfizer (PFE) Earns Daily Media Impact Rating of 0.83
www.americanbankingnews.com - November 14 at 8:58 PM
IVE, WMT, PFE, MRK: Large Inflows Detected at ETFIVE, WMT, PFE, MRK: Large Inflows Detected at ETF
www.nasdaq.com - November 14 at 3:38 PM
Pfizer loses drug patent fight in UK top court, may face claimsPfizer loses drug patent fight in UK top court, may face claims
finance.yahoo.com - November 14 at 3:38 PM
Pfizer loses Lyrica patent fightPfizer loses Lyrica patent fight
seekingalpha.com - November 14 at 10:01 AM
Pfizer loses its Lyrica drug patent fight in UK Supreme CourtPfizer loses its Lyrica drug patent fight in UK Supreme Court
www.cnbc.com - November 14 at 7:24 AM
Pfizer (PFE) Stock Moves -0.38%: What You Should KnowPfizer (PFE) Stock Moves -0.38%: What You Should Know
www.zacks.com - November 13 at 10:00 AM
Pfizer Inc. (PFE) Short Interest Down 7.5% in OctoberPfizer Inc. (PFE) Short Interest Down 7.5% in October
www.americanbankingnews.com - November 13 at 2:40 AM
Positive Media Coverage Unlikely to Impact Pfizer (PFE) Stock PricePositive Media Coverage Unlikely to Impact Pfizer (PFE) Stock Price
www.americanbankingnews.com - November 10 at 7:20 PM
This Health Care Stock Could Pay Off BigThis Health Care Stock Could Pay Off Big
investorplace.com - November 9 at 9:51 AM
Nektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares UpNektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares Up
finance.yahoo.com - November 8 at 3:43 PM
Pfizer (PFE) Given a $53.00 Price Target at Cantor FitzgeraldPfizer (PFE) Given a $53.00 Price Target at Cantor Fitzgerald
www.americanbankingnews.com - November 8 at 12:16 PM
Why Pfizer’s Rare Disease Portfolio Offers a Unique OpportunityWhy Pfizer’s Rare Disease Portfolio Offers a Unique Opportunity
finance.yahoo.com - November 7 at 10:50 AM
Eli Lillys Conservative Pricing Offers Protection From Political PressureEli Lilly's Conservative Pricing Offers Protection From Political Pressure
finance.yahoo.com - November 6 at 3:39 PM
Pfizer (PFE) PT Raised to $37.00Pfizer (PFE) PT Raised to $37.00
www.americanbankingnews.com - November 6 at 10:52 AM
Nektar Therapeutics (NKTR), Pfizer (PBE) Enter Pact to Evaluate Combination of NKTR-214 with Avelumab and ...Nektar Therapeutics (NKTR), Pfizer (PBE) Enter Pact to Evaluate Combination of NKTR-214 with Avelumab and ...
www.streetinsider.com - November 6 at 10:42 AM
Xeljanz: PFE’s Immunology and Inflammation Growth DriverXeljanz: PFE’s Immunology and Inflammation Growth Driver
finance.yahoo.com - November 6 at 10:42 AM
Vaccines Are an Important Growth Driver for PfizerVaccines Are an Important Growth Driver for Pfizer
finance.yahoo.com - November 6 at 10:42 AM
Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Pfizer (PFE) Share PriceSomewhat Favorable Press Coverage Somewhat Unlikely to Affect Pfizer (PFE) Share Price
www.americanbankingnews.com - November 6 at 8:25 AM
Pfizer Inc. (PFE) Receives Consensus Recommendation of "Hold" from BrokeragesPfizer Inc. (PFE) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 6 at 3:20 AM
Analyzing Gilead Sciences’ HIV PortfolioAnalyzing Gilead Sciences’ HIV Portfolio
finance.yahoo.com - November 5 at 8:31 AM
Analyzing Pfizer’s Expense Projections for 2018Analyzing Pfizer’s Expense Projections for 2018
finance.yahoo.com - November 5 at 8:31 AM
Zacks: Brokerages Anticipate Pfizer Inc. (PFE) Will Post Quarterly Sales of $13.91 BillionZacks: Brokerages Anticipate Pfizer Inc. (PFE) Will Post Quarterly Sales of $13.91 Billion
www.americanbankingnews.com - November 4 at 3:26 AM
Pfizer mulling sale of womens health products - BloombergPfizer mulling sale of women's health products - Bloomberg
seekingalpha.com - November 3 at 3:31 PM
FDA OKs Pfizers lorlatinib for lung cancerFDA OKs Pfizer's lorlatinib for lung cancer
seekingalpha.com - November 3 at 10:43 AM
 Brokerages Anticipate Pfizer Inc. (PFE) Will Announce Earnings of $0.64 Per Share Brokerages Anticipate Pfizer Inc. (PFE) Will Announce Earnings of $0.64 Per Share
www.americanbankingnews.com - November 2 at 5:03 PM
Ibrance, Eliquis, And Biosimilars Remain The Key Driver For Pfizers Future Earnings GrowthIbrance, Eliquis, And Biosimilars Remain The Key Driver For Pfizer's Future Earnings Growth
www.forbes.com - November 2 at 3:32 PM
Pfizer’s Earnings Projections for 2018Pfizer’s Earnings Projections for 2018
finance.yahoo.com - November 2 at 3:32 PM
PFE vs. NVO: Which Stock Is the Better Value Option?PFE vs. NVO: Which Stock Is the Better Value Option?
www.zacks.com - November 2 at 11:15 AM
BMO Downgrades Pfizer After Q3 Print, Says Risk-Reward Fairly BalancedBMO Downgrades Pfizer After Q3 Print, Says Risk-Reward 'Fairly Balanced'
www.benzinga.com - November 2 at 11:15 AM
Evaluating Pfizers Growth Plans And ValuationEvaluating Pfizer's Growth Plans And Valuation
seekingalpha.com - November 2 at 11:15 AM
Here’s How Pfizer Stock Moved in OctoberHere’s How Pfizer Stock Moved in October
finance.yahoo.com - November 2 at 11:15 AM
Drug giant Pfizer says it will return to business as normal, which means price hikesDrug giant Pfizer says it will return to 'business as normal,' which means price hikes
www.latimes.com - November 2 at 8:58 AM
Pfizer (PFE) said to Weigh Sale of $2B Womens Health Portfolio - BloombergPfizer (PFE) said to Weigh Sale of $2B Women's Health Portfolio - Bloomberg
www.streetinsider.com - November 1 at 3:37 PM
PFE vs. NVO: Which Stock Should Value Investors Buy Now?PFE vs. NVO: Which Stock Should Value Investors Buy Now?
www.zacks.com - November 1 at 3:37 PM
Pfizer cut to market perform at BMOPfizer cut to market perform at BMO
finance.yahoo.com - November 1 at 3:37 PM
Pfizer (PFE) Downgraded by BMO Capital MarketsPfizer (PFE) Downgraded by BMO Capital Markets
www.americanbankingnews.com - November 1 at 2:15 PM
Pfizer (PFE) Given a $43.00 Price Target by Societe Generale AnalystsPfizer (PFE) Given a $43.00 Price Target by Societe Generale Analysts
www.americanbankingnews.com - November 1 at 12:47 PM
Pfizer downgraded by BMO: Significant headwinds will cap the drugmakers stock runPfizer downgraded by BMO: 'Significant headwinds' will cap the drugmaker's stock run
finance.yahoo.com - November 1 at 10:12 AM
Pfizer beats by $0.03, misses on revenuePfizer beats by $0.03, misses on revenue
seekingalpha.com - October 31 at 10:43 AM
Gauging Analysts’ Views on Bristol-Myers Squibb StockGauging Analysts’ Views on Bristol-Myers Squibb Stock
finance.yahoo.com - October 31 at 10:42 AM
This page was last updated on 11/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel